• Explore /
  • Poster
  • / SUNRAY-01, a pivotal, global study of olomorasib (LY3537982) in combination with pembrolizumab with or without chemotherapy for 1L treatment in <em>KRAS</em> G12C-mutant advanced NSCLC.

SUNRAY-01, a pivotal, global study of olomorasib (LY3537982) in combination with pembrolizumab with or without chemotherapy for 1L treatment in KRAS G12C-mutant advanced NSCLC.

Abstract Poster

Authors

null

Makoto Nishio

Department of Thoracic Medical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan

Makoto Nishio , Marcelo Vailati Negrao , Kathryn C. Arbour , Timothy F. Burns , Federico Cappuzzo , Anne-Marie C. Dingemans , Nicolas Girard , Bjorn Henning Gronberg , Maximilian Hochmair , Ticiana Leal , Colin R. Lindsay , Shun Lu , Luis G. Paz-Ares , Martin Reck , Joshua K. Sabari , Alexander I. Spira , William Nassib William Jr., Aaron Chen , Carla M. Visseren Grul , Solange Peters

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Breakthrough

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session B

Track

Thoracic Cancers,Breast Cancer,Gynecologic Cancer,Head and Neck Cancer,Hematologic Malignancies,Genetics/Genomics/Multiomics,Healthtech Innovations,Models of Care and Care Delivery,Viral-Mediated Malignancies,Other Malignancies or Topics

Sub Track

Targeted Therapies

Clinical Trial Registration Number

NCT06119581

Citation

J Clin Oncol 42, 2024 (suppl 23; abstr TPS218)

DOI

10.1200/JCO.2024.42.23_suppl.TPS218

Abstract #

TPS218

Poster Bd #

L9

Abstract Disclosures

Similar Posters

First Author: Luis G. Paz-Ares

First Author: Martin Reck

First Author: Meredith Pelster

First Author: Sun Young Rha